• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis.

作者信息

Armbrust W, Kamphuis S S M, Wolfs T W F, Fiselier T J W, Nikkels P G, Kuis W, Wulffraat N M

出版信息

Rheumatology (Oxford). 2004 Apr;43(4):527-9. doi: 10.1093/rheumatology/keh074.

DOI:10.1093/rheumatology/keh074
PMID:15024141
Abstract
摘要

相似文献

1
Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis.一名九岁女童因系统性幼年特发性关节炎接受英夫利昔单抗治疗后发生的结核病。
Rheumatology (Oxford). 2004 Apr;43(4):527-9. doi: 10.1093/rheumatology/keh074.
2
Delayed maculopapular, urticarial rash due to infliximab in two children with systemic onset juvenile idiopathic arthritis.两名系统性发作幼年特发性关节炎患儿因英夫利昔单抗出现延迟性斑丘疹、荨麻疹样皮疹。
Rheumatology (Oxford). 2004 May;43(5):674-5. doi: 10.1093/rheumatology/keh142.
3
Crusted scabies in a patient being treated with infliximab for juvenile rheumatoid arthritis.
J Am Acad Dermatol. 2005 Apr;52(4):719-20. doi: 10.1016/j.jaad.2004.12.039.
4
Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al.英夫利昔单抗治疗三年后类风湿关节炎患者发生致命性肺结核：对Wolfe等人文章的评论
Arthritis Rheum. 2005 Apr;52(4):1334-6. doi: 10.1002/art.20973.
5
Tuberculosis and treatment with infliximab.
N Engl J Med. 2002 Feb 21;346(8):623-6.
6
[Fatal miliary tuberculosis during treatment with infliximab].
Ned Tijdschr Geneeskd. 2002 Jun 22;146(25):1196-9.
7
[Case of miliary tuberculosis during treatment with infliximab for rheumatoid arthritis].[类风湿关节炎患者使用英夫利昔单抗治疗期间发生粟粒性肺结核的病例]
Kekkaku. 2008 May;83(5):431-4.
8
Atypical cutaneous tuberculosis in a patient with rheumatoid arthritis treated with infliximab.一名使用英夫利昔单抗治疗的类风湿关节炎患者发生的非典型皮肤结核。
Acta Derm Venereol. 2008;88(2):183-4. doi: 10.2340/00015555-0367.
9
Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.重复静脉输注抗肿瘤坏死因子α单克隆抗体英夫利昔单抗治疗持续活动、难治性幼年特发性关节炎的疗效：一项开放标签前瞻性研究的结果
Arthritis Rheum. 2005 Feb;52(2):548-53. doi: 10.1002/art.20793.
10
Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.在一项对163例患者的开放性单中心长期前瞻性研究中，关注肿瘤坏死因子α阻滞剂在幼年特发性关节炎中的不良事件。
Ann Rheum Dis. 2008 Aug;67(8):1145-52. doi: 10.1136/ard.2007.069484. Epub 2007 Nov 2.

引用本文的文献

1
THE ROLE OF INTERFERON-GAMMA RELEASE ASSAYS IN DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN CHILDREN.γ-干扰素释放试验在儿童潜伏结核感染诊断中的作用。
Acta Clin Croat. 2023 Nov;62(3):527-538. doi: 10.20471/acc.2023.62.03.15.
2
Tuberculosis in pediatric patients treated with anti-TNFα drugs: a cohort study.接受抗TNFα药物治疗的儿科患者中的结核病：一项队列研究。
Pediatr Rheumatol Online J. 2015 Dec 3;13:54. doi: 10.1186/s12969-015-0054-4.
3
A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors.
一项前瞻性研究，比较接受和未接受肿瘤坏死因子-α抑制剂治疗的幼年特发性关节炎患儿的感染风险和疾病活动情况。
Clin Rheumatol. 2015 Mar;34(3):457-64. doi: 10.1007/s10067-014-2779-8. Epub 2014 Sep 18.
4
Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature.儿童和青少年幼年特发性关节炎和炎症性肠病患者接受肿瘤坏死因子-α抑制剂治疗后的感染：文献系统评价。
Clin Infect Dis. 2013 Nov;57(9):1318-30. doi: 10.1093/cid/cit489. Epub 2013 Jul 29.
5
What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?长期使用生物疗法治疗青少年特发性关节炎会产生哪些免疫方面的后果？
Arthritis Res Ther. 2013;15(3):213. doi: 10.1186/ar4213.
6
Ocular complications associated with systemic medications used in allergy/immunology practice.与过敏/免疫学实践中使用的全身药物相关的眼部并发症。
Curr Allergy Asthma Rep. 2013 Jun;13(3):329-35. doi: 10.1007/s11882-012-0333-9.
7
Fatal group A Streptococcus purpura fulminans in a child receiving TNF-α blocker.儿童接受 TNF-α 阻滞剂后发生致死性 A 组链球菌坏死性筋膜炎。
Eur J Pediatr. 2011 May;170(5):657-60. doi: 10.1007/s00431-010-1341-1. Epub 2010 Nov 10.
8
The safety profile of biologic therapies for juvenile idiopathic arthritis.生物制剂治疗幼年特发性关节炎的安全性特征。
Nat Rev Rheumatol. 2010 Oct;6(10):561-71. doi: 10.1038/nrrheum.2010.142. Epub 2010 Aug 31.
9
Serious musculoskeletal infections in children receiving anti-tumor necrosis factor-alpha therapy: a case series.儿童接受抗肿瘤坏死因子-α治疗后的严重肌肉骨骼感染：病例系列研究。
Clin Rheumatol. 2010 Jun;29(6):677-81. doi: 10.1007/s10067-010-1410-x. Epub 2010 Apr 10.
10
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.治疗幼年特发性关节炎的生物疗法：来自成人和儿童治疗经验的启示。
Biologics. 2008 Jun;2(2):229-52. doi: 10.2147/btt.s2210.